1.
Gunturu KS, Abu-Khalaf M, Saif MW. Hepatic Failure and Hepatorenal Syndrome Secondary to Erlotinib: A Possible Etiology of Complications in a Patient with Pancreatic Cancer. JOP. J Pancreas (Online) [Internet]. 2010 Sep. 6 [cited 2025 May 3];11(5):484-5. Available from: https://serena.sharepress.it/index.php/jop/article/view/3443